A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.

Summary

Mitral valve regurgitation (leakage of the mitral valve of the heart) is frequent and currently there is no specific medical therapy. Mitral regurgitation is a slowly progressive disease that frequently requires surgical treatment. This randomized clinical trial will use Metoprolol, a common beta-blocker medication, to determine if medical treatment impacts mitral valve disease progression.

Timeline

Start

2004-07

Primary completion

2007-07

Completion

2007-07

Drugs

Indications